상세 보기
Phase II trial of lazertinib in EGFR-mutated metastatic non-small cell lung cancer patients with brain metastases after failure to prior EGFR tyrosine kinase inhibitor (KCSG LU 20-15)
Phase II trial of lazertinib in EGFR-mutated metastatic non-small cell lung cancer patients with brain metastases after failure to prior EGFR tyrosine kinase inhibitor (KCSG LU 20-15)
- 제목
- Phase II trial of lazertinib in EGFR-mutated metastatic non-small cell lung cancer patients with brain metastases after failure to prior EGFR tyrosine kinase inhibitor (KCSG LU 20-15)
- 제목 (타언어)
- Phase II trial of lazertinib in EGFR-mutated metastatic non-small cell lung cancer patients with brain metastases after failure to prior EGFR tyrosine kinase inhibitor (KCSG LU 20-15)
- 저자
- Yoon Ji Choi
- 발행일
- 2023-09-08
- 학회명
- KSMO 2023 16th annual meeting of the Korean Society of Medical Oncology & 2023 International Conference
- 개최국가
- 대한민국
- 학회 개최일
- 2023-09-07 ~ 2023-09-08